Option chain shows key data for Moberg Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Moberg Pharma.

Moberg Pharma (OTC:MBGPF) Stock, Option Chain

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.

Moberg Pharma AB

<p>Highlighting Commitment To Driver Empowerment With 0% Commission Policy And Enhanced Rider Experience Through AI-Driven Features And Subscription Model Ryde+</p>


News

RYDE

Ryde Secures 3-Year Renewal Of Ride-Hail And Carpool Licenses In Singapore

<p><strong>Nano Dimension Ltd</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNDM#NASDAQ">NNDM</a>) shares are trading higher Thursday after the company announced a <a href="https://www.benzinga.com/pressreleases/24/12/g42684172/nano-dimension-announces-ceo-transition">CEO transition</a>.</p>
<p><strong>What Happened:</strong> Nano Dimension announced Thursday that <strong>Yoav Stern&#8217;s</strong> role as CEO has been terminated, effective immediately, and the company has begun searching for a permanent replacement. </p>
<p>Stern had been serving as CEO and a member of the company&#8217;s board since January 2020, but he failed to be re-elected as a director at the company&#8217;s 2024 annual meeting of shareholders. </p>
<p><strong>Julien Lederman&nbsp;</strong>has been appointed as interim CEO while the board conducts a comprehensive search for a replacement. </p>
<p>Lederman has served as vice president of corporate development since March 2021, and previously worked at Amazon, Goldman Sachs, Lehman Brothers and World Economic Forum. </p>
<p>&#8220;The Board is pleased and confident in our appointment of Julien Lederman as Interim Chief Executive Officer. The Board fully supports Julien during this transition period while we conduct a broad search for a permanent Chief Executive Officer,&#8221; said <strong>Ofir Baharav</strong>, chairman of Nano Dimension&#8217;s board.</p>
<h3 class="wp-block-heading">How To Buy NNDM Stock</h3>
<p>Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. </p>
<p>For example, in Nano Dimension's case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.</p>
<p><strong>NNDM Price Action:</strong> <a href="http://benzinga.com/quote/nndm">Nano Dimension shares</a> were up 5.60% at $2.66 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42682230/tech-bull-predicts-26-upside-for-apple-stock-sees-golden-era-of-growth-for-cupertino-due-to-multi-year-ai-driven-iphone-upgrade-cycle"><strong>Tech Bull Predicts 26% Upside For Apple Stock, Sees &#8216;Golden Era Of Growth&#8217; For Cupertino Due To Multi-Year AI-Driven iPhone Upgrade Cycle</strong></a></li>
</ul>
<p><em>Photo: courtesy of Nano Dimension.</em></p>


Management

Movers

NNDM

Nano Dimension Shares Are Rising Thursday: What's Going On?

<p><strong>The Global Engagement Center</strong> (GEC), a U.S. State Department unit established in 2016 to counter foreign disinformation, has shut down after Congress failed to extend its funding.</p>
<p>&#8220;The Global Engagement Center closed on December 23, 2024,&#8221; it <a target="_blank" href="https://www.state.gov/bureaus-offices/under-secretary-for-public-diplomacy-and-public-affairs/global-engagement-center/#:~:text=The%20Global%20Engagement%20Center%20closed%20on%20December%2023%2C%202024." rel="noreferrer noopener">said</a> on its website.</p>
<p>The closure comes amid growing concerns over disinformation campaigns from adversaries like Russia and China, mainly as they target global narratives and U.S. interests, <a target="_blank" href="https://www.aljazeera.com/news/2024/12/25/us-government-agency-targeting-foreign-disinformation-shuts-down" rel="noreferrer noopener">reports</a> Al Jazeera.</p>
<p>The GEC, with a budget of $61 million and a staff of about 120, was responsible for tracking and responding to foreign propaganda.</p>
<p>Its closure marks the first time in eight years that the State Department will lack a dedicated office to address disinformation from global rivals, Al Jazeera adds.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42681352/us-futures-tumble-after-christmas-break-but-analysts-still-expect-a-santa-claus-rally" rel="noreferrer noopener">US Stocks Likely To Open In Red After Christmas Break But Analysts Still Expect A Santa Rally Into The New Year</a></strong></p>
<p>The decision to terminate the GEC follows persistent criticism from Republican lawmakers who accused the center of censorship and surveillance of Americans.</p>
<p>The center also faced attacks from high-profile figures such as <strong>Elon Musk</strong>, who labeled it for media manipulation and the &#8220;worst offender in US government censorship.&#8221;</p>
<p>Despite these criticisms, GEC leaders defended their work, emphasizing its importance in combating foreign propaganda.</p>
<p>The GEC&#8217;s closure leaves a significant gap in U.S. efforts to counter misinformation campaigns, particularly those from Russia regarding the war in Ukraine and China&#8217;s global disinformation initiatives.</p>
<p>In response, the State Department has said it is consulting with Congress on potential next steps.</p>
<p>Meanwhile, the GEC&#8217;s shutdown follows the stripping of a funding extension from the final version of the bipartisan federal spending bill passed by Congress last week, Al Jazeera further adds.</p>
<p><strong>Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42678014/top-7-blue-chip-stocks-with-the-best-return-potential-going-into-2025" rel="noreferrer noopener">S&amp;P 500 Hits 57 All-Time Highs In Record-Breaking 2024: Magnificent 7 Drive 30% Of Nasdaq's Surge</a></strong></p>


Government

Regulations

Politics

Markets

Media

General

US State Department Shuts Down Global Engagement Center Amid Funding Issues

<p>High-rolling investors have positioned themselves bearish on AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in APP often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 11 options trades for AppLovin. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 36% bullish and 45% bearish. Among all the options we identified, there was one put, amounting to $26,710, and 10 calls, totaling $1,570,997.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $80.0 to $610.0 for AppLovin over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for AppLovin's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across AppLovin's significant trades, within a strike price range of $80.0 to $610.0, over the past month.</p>
<h3>AppLovin 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735224350_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>APP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$264.6</td>
<td>$263.1</td>
<td>$264.6</td>
<td>$82.50</td>
<td>$370.4K</td>
<td align="right">205</td>
<td align="right">44</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$267.3</td>
<td>$265.3</td>
<td>$265.3</td>
<td>$82.50</td>
<td>$318.3K</td>
<td align="right">205</td>
<td align="right">30</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$51.2</td>
<td>$49.1</td>
<td>$50.0</td>
<td>$350.00</td>
<td>$250.0K</td>
<td align="right">231</td>
<td align="right">50</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$266.8</td>
<td>$263.1</td>
<td>$264.6</td>
<td>$82.50</td>
<td>$211.6K</td>
<td align="right">205</td>
<td align="right">8</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$130.9</td>
<td>$128.0</td>
<td>$128.0</td>
<td>$220.00</td>
<td>$153.6K</td>
<td align="right">91</td>
<td align="right">12</td>
</tr>
</tbody>
</table>
</p>
<h3>About AppLovin</h3>
<p>AppLovin Corp is a mobile app technology company. It focuses on growing the mobile app ecosystem by enabling the success of mobile app developers. The company's software solutions provide tools for mobile app developers to grow their businesses by automating and optimizing the marketing and monetization of their applications.</p>
<p>Following our analysis of the options activities associated with AppLovin, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of AppLovin</h3>
<ul>
<li>With a volume of 41,399, the price of APP is down -0.63% at $339.69. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 48 days.</li>
</ul>
<h3>Professional Analyst Ratings for AppLovin</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $455.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Macquarie continues to hold a Outperform rating for AppLovin, targeting a price of $450.<br />
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Buy rating on AppLovin with a target price of $450.<br />
&#x2A; An analyst from Stifel persists with their Buy rating on AppLovin, maintaining a target price of $435.<br />
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for AppLovin, targeting a price of $460.<br />
&#x2A; In a cautious move, an analyst from Oppenheimer downgraded its rating to Outperform, setting a price target of $480. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for AppLovin, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

AppLovin Options Trading: A Deep Dive into Market Sentiment

<p>Financial giants have made a conspicuous bullish move on Boeing. Our analysis of options history for Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) revealed 12 unusual trades.</p>
<p>Delving into the details, we found 75% of traders were bullish, while 16% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $88,250, and 10 were calls, valued at $441,683.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $155.0 to $210.0 for Boeing over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Boeing's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Boeing's substantial trades, within a strike price spectrum from $155.0 to $210.0 over the preceding 30 days.</p>
<h3>Boeing Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735224345_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.0</td>
<td>$5.85</td>
<td>$6.0</td>
<td>$180.00</td>
<td>$167.4K</td>
<td>22.1K</td>
<td align="right">307</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$11.55</td>
<td>$11.45</td>
<td>$11.45</td>
<td>$180.00</td>
<td>$57.2K</td>
<td>574</td>
<td align="right">50</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$29.7</td>
<td>$29.4</td>
<td>$29.7</td>
<td>$160.00</td>
<td>$41.5K</td>
<td>1.1K</td>
<td align="right">14</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$29.75</td>
<td>$29.65</td>
<td>$29.75</td>
<td>$155.00</td>
<td>$35.7K</td>
<td>3.3K</td>
<td align="right">12</td>
</tr>
<tr>
<td>BA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$31.6</td>
<td>$30.5</td>
<td>$31.6</td>
<td>$160.00</td>
<td>$31.6K</td>
<td>1.3K</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About Boeing</h3>
<p>Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and Global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with Lockheed, Northrop, and several other firms to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.</p>
<p>Following our analysis of the options activities associated with Boeing, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Boeing</h3>
<ul>
<li>Trading volume stands at 156,743, with BA's price up by 0.14%, positioned at $179.59.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 34 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Boeing with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Unpacking the Latest Options Trading Trends in Boeing

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Alibaba Gr Hldgs</strong>.</p>
<p>Looking at options history for Alibaba Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) we detected 9 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish expectations and 11% with bearish.</p>
<p>From the overall spotted trades, 2 are puts, for a total amount of $59,140 and 7, calls, for a total amount of $350,500.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $97.5 for Alibaba Gr Hldgs over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Alibaba Gr Hldgs's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Alibaba Gr Hldgs's whale activity within a strike price range from $75.0 to $97.5 in the last 30 days. </p>
<h3>Alibaba Gr Hldgs Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735224340_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$13.1</td>
<td>$12.9</td>
<td>$12.96</td>
<td>$75.00</td>
<td>$129.7K</td>
<td>745</td>
<td align="right">100</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$6.0</td>
<td>$5.8</td>
<td>$5.95</td>
<td>$90.00</td>
<td>$59.5K</td>
<td>3.5K</td>
<td align="right">100</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$11.9</td>
<td>$11.7</td>
<td>$11.9</td>
<td>$85.00</td>
<td>$47.6K</td>
<td>1.5K</td>
<td align="right">40</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$3.1</td>
<td>$2.62</td>
<td>$3.1</td>
<td>$87.00</td>
<td>$31.0K</td>
<td>137</td>
<td align="right">100</td>
</tr>
<tr>
<td>BABA</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$16.7</td>
<td>$14.3</td>
<td>$15.5</td>
<td>$97.50</td>
<td>$31.0K</td>
<td>1.5K</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About Alibaba Gr Hldgs</h3>
<p>Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China commerce retail division is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China commerce wholesale, international commerce retail/wholesale, local consumer services, cloud computing, digital media and entertainment platforms, Cainiao logistics services, and innovation initiatives/other.</p>
<p>Having examined the options trading patterns of Alibaba Gr Hldgs, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Alibaba Gr Hldgs</h3>
<ul>
<li>Currently trading with a volume of 239,160, the BABA's price is up by 0.39%, now at $85.85. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 41 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Alibaba Gr Hldgs with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


BABA

This Is What Whales Are Betting On Alibaba Gr Hldgs

Trading Ideas

MGIH

Millennium Group International Shares Resume Trade

<p><strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is trading around $95,500, down 3.4% over the past 24 hours, as on-chain data and whale activity suggest predictions of an imminent bear market <a href="https://www.benzinga.com/money/bitcoin-price-prediction">lack substantial evidence</a>.  </p>
<p><strong>What Happened:</strong>  <strong>Ki Young Ju</strong>, founder of CryptoQuant, pointed out in a <a href="https://x.com/ki_young_ju/status/1872207964352004106">post</a> on <strong>X</strong> on Dec. 26 that whale accumulation, once market-moving news, has now become a routine phenomenon. </p>
<p>This indicates a market dominated by institutional players, while retail investors remain hesitant.</p>
<p>A $7 billion weekly capital inflow confirms Bitcoin is in a bull cycle, not a bubble. </p>
<p>A true bubble—marked by a market price far exceeding capital inflows—would spark warnings of a cyclical top, which analysts have yet to issue.</p>
<p>Brief corrections of up to 30% are possible but unlikely to derail the ongoing bull cycle. The cycle's peak is still distant, and predictions of a bear market lack support from on-chain data.</p>
<p>In another post on the same day, he <a href="https://x.com/ki_young_ju/status/1872162768570425845">revealed</a> whales are increasingly utilizing privacy transactions for accumulation. </p>
<p>Of the 1.55 million BTC accumulated in 2024 through ETFs, MicroStrategy,and custodial wallets, 240,000–420,000 BTC remain unaccounted for, signalling large, unidentified buyers.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42656507/bitcoin-price-decisively-back-below-100000-what-is-going-on">Bitcoin Price Decisively Back Below $100,000: What Is Going On?</a></strong></p>
<p><strong>Why It Matters:</strong> Traders maintain their optimism around upcoming price patterns for the crypto king.</p>
<p>Crypto trader Jelle sees the recent Bitcoin volatility as insignificant in the bigger picture. </p>
<p>The trend remains upward, with dips acting as minor speed bumps. He advised his followers to "stay focused."</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">When you look at the grand scheme of things, it&#39;s almost as if the volatility from the past weeks does not matter.<a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> keep pushing higher, dips are just speed bumps along the route.<br /><br />Stay focussed. <a href="https://t.co/MknV2INpYu">pic.twitter.com/MknV2INpYu</a></p>
<p>&mdash; Jelle (@CryptoJelleNL) <a href="https://twitter.com/CryptoJelleNL/status/1872235469372887200?ref_src=twsrc%5Etfw">December 26, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>On the other hand, crypto chart analyst Ali Martinez flagged a buy signal on Bitcoin's hourly chart which implies a price rebound.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">The TD Sequential presented a buy signal on the <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> hourly chart, anticipating a price rebound. <a href="https://t.co/AW8Ks17mRx">pic.twitter.com/AW8Ks17mRx</a></p>
<p>&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1872246246263714252?ref_src=twsrc%5Etfw">December 26, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42638493/crypto-analyst-2025-will-continue-to-be-a-great-year-for-bitcoin">Crypto Analyst: &#8216;2025 Will Continue To Be a Great Year for Bitcoin&#8217;</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Drops 3% To $95,500: What Is Going On?

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Raymond James analyst C. Gregory Peters upgraded the rating for <strong>The Progressive Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) from Market Perform to Outperform and announced a $305 price target. Progressive shares closed at $243.24 on Tuesday. <a href="https://www.benzinga.com/quote/PGR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Raymond James analyst Aaron Kessler upgraded <strong>EverQuote, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) from Outperform to Strong Buy and maintained the price target of $35. EverQuote shares closed at $18.32 on Tuesday. <a href="https://www.benzinga.com/quote/EVER/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Raghuram Selvaraju upgraded the rating for <strong>RAPT Therapeutics, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) from Neutral to Buy and maintained the price target of $10. RAPT Therapeutics shares closed at $1.73 on Tuesday. <a href="https://www.benzinga.com/quote/RAPT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
<p>Considering buying PGR stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210-1024x598.png" alt="" class="wp-image-707746" style="width:365px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210-1024x598.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210-768x448.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26093624/image-210.png 1057w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/12/42669200/wall-streets-most-accurate-analysts-give-their-take-on-3-utilities-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Utilities Stocks With Over 4% Dividend Yields</a></strong></li>
</ul>


Upgrades

Analyst Ratings

EVER

RAPT

This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday

Millennium Group International Shares Halted To The Upside; Stock Now Up 245.75%

WIIM

AMPG

AmpliTech Group shares are trading lower after the company announced the pricing of a $5.8 million registered direct offering for 1.87 million shares at $3.10 per share.

<p><strong>KULR Technology Group Inc</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares are trading higher Thursday after the company announced a <strong>Bitcoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) purchase under its newly-adopted <a href="https://www.benzinga.com/pressreleases/24/12/g42683875/kulr-launches-bitcoin-treasury-with-purchase-of-217-18-bitcoin-for-21-million">Bitcoin Treasury strategy</a>. </p>
<p><strong>What To Know:</strong> At the beginning of December, KULR announced plans to include Bitcoin as a primary asset in its treasury program. The company said that it planned to allocate up to 90% of its surplus cash to Bitcoin. </p>
<p>&#8220;Given the unique characteristics of BTC, it provides long term appreciation and a bulwark against geopolitical, inflationary, and other macro-economic and political trends affecting all developed economies,&#8221; said <strong>Michael Mo</strong>, chairman and CEO of KULR Technology.</p>
<p>On Thursday, KULR announced that it purchased 217.18 <a href="https://www.benzinga.com/quote/BTC-USD">Bitcoin</a> for approximately $21 million. The purchases were made at an average price of $96,556.53 per Bitcoin. </p>
<p>KULR selected Coinbase Prime for wallet services for its Bitcoin. The company noted that this is the first purchase in a string of expected ongoing purchases the company expects to make going forward under its Bitcoin Treasury strategy. </p>
<p><strong>See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42682141/dogecoin-price-down-4-what-is-going-on">Dogecoin Price Down 4%: What Is Going On?</a></strong></p>
<p><strong>KULR Price Action:</strong> <a href="http://benzinga.com/quote/KULR">KULR Technology shares</a> were up 2.19% at $3.49 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><em>Photo: Shutterstock.</em></p>


KULR

What's Going On With KULR Technology Group Stock Today?

<p>In the current market session, <strong>Xcel Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XEL#NASDAQ">XEL</a>)</strong> share price is at $68.58, after a <strong>0.54%</strong> spike. Moreover, over the past month, the stock decreased by <strong>6.37%</strong>, but in the past year, increased by <strong>9.74%</strong>. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735223411_0.png" alt="Past Year Chart" /></p>

<h3>Xcel Energy P/E Ratio Analysis in Relation to Industry Peers</h3>
<p>The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. </p>
<p>Xcel Energy has a better P/E ratio of <strong>20.24</strong> than the aggregate P/E ratio of <strong>17.84</strong> of the Electric Utilities industry. Ideally, one might believe that Xcel Energy Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735223411_1.png" alt="Guage" /></p>

<p>In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions. </p>


Intraday Update

Price Over Earnings Overview: Xcel Energy

<p>During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.</p>
<p>Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.</p>
<p>Below are the ratings of the most accurate analysts for three high-yielding stocks in the communication services sector.</p>
<h3 class="wp-block-heading"><strong>Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 6.81%</li>
<li><strong>UBS </strong>analyst John Hodulik maintained a Neutral rating and raised the price target from $44 to $45 on Dec. 20. This analyst has an accuracy rate of 76%.</li>
<li><strong>Scotiabank </strong>analyst Maher Yaghi maintained a Sector Perform rating and cut the price target from $47.25 to $47 on Oct. 23. This analyst has an accuracy rate of 62%.</li>
<li><strong>Recent News:</strong> On Dec. 23, Vertical Bridge completed $3.3 billion tower transaction with Verizon.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1">latest VZ news</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="911" height="848" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092320/image-207.png" alt="" class="wp-image-707724" style="width:631px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092320/image-207.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092320/image-207-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092320/image-207-768x715.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Sinclair, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBGI#NASDAQ">SBGI</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 6.29%</li>
<li><strong>Guggenheim </strong>analyst Curry Baker maintained a Buy rating and raised the price target from $18 to $19 on Oct. 19. This analyst has an accuracy rate of 60%.</li>
<li><strong>JP Morgan </strong>analyst David Karnovsky maintained an Underweight rating and raised the price target from $14 to $16 on Nov. 12. This analyst has an accuracy rate of 69%.</li>
<li><strong>Recent News: O</strong>n Dec. 17, Sinclair expanded Broadcast Network Footprint of TBD TV through partnership with FOX in top 10 DMAs.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1">latest SBGI news</a> </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="906" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092359/image-208.png" alt="" class="wp-image-707726" style="width:597px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092359/image-208.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092359/image-208-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092359/image-208-768x709.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Playtika Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTK#NASDAQ">PLTK</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield: </strong>5.88%</li>
<li><strong>Roth MKM </strong>analyst Eric Handler maintained a Neutral rating and raised the price target from $8 to $9 on Nov. 8. This analyst has an accuracy rate of 72%.</li>
<li><strong>Wedbush </strong>analyst Michael Pachter reiterated an Outperform rating and a price target of $11.5 on Sept. 19. This analyst has an accuracy rate of 64%.</li>
<li><strong>Recent News: </strong>On Dec. 20, Playtika announced a partnership with IGT, a global gaming leader.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1">trend in PLTK stock</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="903" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092457/image-209.png" alt="" class="wp-image-707729" style="width:600px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092457/image-209.png 903w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092457/image-209-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/26092457/image-209-768x715.png 768w" sizes="(max-width: 903px) 100vw, 903px" /></a></figure></p>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/12/42669200/wall-streets-most-accurate-analysts-give-their-take-on-3-utilities-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Utilities Stocks With Over 4% Dividend Yields</a></strong></li>
</ul>


Dividends

Price Target

Pre-Market Outlook

PLTK

SBGI

Wall Street's Most Accurate Analysts Weigh In On 3 Tech And Telecom Stocks With Over 5% Dividend Yields

<p><strong>Toyota Motor Corp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) shares are trading higher Thursday following reports the company is targeting higher <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42680713/tesla-toyota-and-3-stocks-to-watch-heading-into-thursday">return-on-equity</a>. </p>
<p><strong>What To Know:</strong> According to a Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-12-26/toyota-shares-gain-second-day-after-report-on-roe-target?embedded-checkout=true">report</a> citing Nikkei Asia, Toyota shares jumped on Thursday morning on reports the Japanese automaker is planning to significantly increase its target for return-on-equity. </p>
<p>A Toyota executive reportedly said the company plans to double its target to around 20%, although the unspecified executive noted that the company has not set an &#8220;explicit target&#8221; or deadline for its goal.</p>
<p>"The company would need to boost earnings from the value chain, in order to further propel profit margins upward," Morgan Stanley MUFG Securities analyst Shinji Kakiuchi reportedly said in a new note.</p>
<p>"We'll also be watching for Toyota, as a part of moves to improve capital efficiency, to take funds from selling its equity holdings to bolster shareholder returns further."</p>
<p><strong>See Also: <a href="https://www.benzinga.com/24/12/42681352/us-futures-tumble-after-christmas-break-but-analysts-still-expect-a-santa-claus-rally">US Stocks Likely To Open In Red After Christmas Break But Analysts Still Expect A Santa Rally Into The New Year</a></strong></p>
<h3 class="wp-block-heading">Is TM A Good Stock To Buy?</h3>
<p>When deciding whether to buy a stock, there are some key fundamentals investors may want to consider. One of these factors is revenue growth. Buying a stock is essentially a bet that the business will continue to grow and generate profits in the future.</p>
<p>Toyota Motor has reported average annual revenue growth of 6.86% over the past five years.</p>
<p>It's also important to pay attention to valuation when deciding whether to buy a stock. Toyota Motor has a forward P/E ratio of 9.49. This means investors are paying $9.49 for each dollar of expected earnings in the future. The average forward P/E ratio of Toyota Motor's peers is 37.96.</p>
<p>Other important metrics to look at include a company's profitability, balance sheet, performance relative to a benchmark index and valuation compared to peers. For in-depth analysis tools and important financial data, check out <a href="https://pro.benzinga.com">Benzinga PRO</a>. </p>
<p><strong>TM Price Action:</strong><a href="http://benzinga.com/quote/tm"><strong> </strong>Toyota Motor shares</a> were up 7.48% at $195.01 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><em>Photo: Shutterstock.</em></p>


Toyota Motor Stock Is Trading Higher Thursday: What's Driving The Action?

<p><strong>SciSparc Ltd. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>) shares are rocketing on Thursday after it disclosed that <strong>AutoMax Motors Ltd.</strong>, an Israeli automotive importer and distributor with which it has a merger agreement, has received its $13 million first delivery of JAC vehicles from <strong><a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42681304/scisparc-automax-announces-13-million-first-delivery-of-jac-vehicles-following-regulatory-approval" rel="noreferrer noopener">Anhui Jianghuai Automobile Group Co., Ltd</a></strong>. (JAC Motors).</p>
<p>This marks a key milestone in AutoMax&#8217;s direct import and distribution operations initiated earlier this year under agreements with JAC Motors.</p>
<p>With regulatory approvals in place, AutoMax is set to begin marketing and sales activities for JAC Motors vehicles across Israel.</p>
<p>SciSparc has provided financial support to AutoMax, enabling the resources necessary to facilitate the JAC Motors transaction.</p>
<p>As part of its growth strategy, SciSparc entered into a merger agreement with AutoMax in April 2024.</p>
<p>If completed, this merger would expand SciSparc into the automotive sector, subject to shareholder approval and other closing conditions.</p>
<p>This month, SciSparc disclosed an amendment to its non-binding letter of intent (LOI) regarding the spin-off of its advanced clinical-stage pharmaceutical portfolio and <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42505822/scisparc-provides-updates-on-status-of-spin-off-of-its-advanced-clinical-stage-pharmaceutical-port" rel="noreferrer noopener">equity stake in </a><strong><a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42505822/scisparc-provides-updates-on-status-of-spin-off-of-its-advanced-clinical-stage-pharmaceutical-port" rel="noreferrer noopener">SciSparc Nutraceuticals Inc</a></strong>.</p>
<p><strong>Price Action</strong>: SPRC shares are trading higher by 256% at $0.7874 premarket at the last check Thursday.</p>
<p><strong>Read Next</strong>:</p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cannabis/24/09/41107692/pharma-company-gets-fda-green-light-for-next-phase-trial-for-tourette-syndrome" target="_blank" rel="noreferrer noopener">Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome</a></strong></li>
</ul>
<p><em>Image via Shutterstock.</em></p>


Equities

Small Cap

SPRC

SciSparc Shares Skyrocket With AutoMax's First JAC Motors Shipment

Offerings

AmpliTech Group Prices $5.8M Registered Direct Offering For 1.87M Shares At $3.10 Per Share To Support Growth Initiatives

<ul>
<li>TSLA</li>
<li>NVDA</li>
<li>LUNR</li>
<li>AMD</li>
<li>ACHR</li>
<li>QQQ</li>
<li>$BTC</li>
<li>MSTR</li>
<li>PLTR</li>
<li>GOOGL</li>
</ul>
<p>Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a></p>
<p>&nbsp;</p>


ACHR

GOOGL

LUNR

MSTR

NVDA

PLTR

TSLA

Top 10 Trending Stocks On WallStreetBets As Of December 26, 2024 (Via Swaggy Stocks)

<p>UBS  analyst Jay Sole   reiterates Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Neutral and maintains $73 price target.</p>


Reiteration

UBS Reiterates Neutral on Nike, Maintains $73 Price Target

<p>In the current market session, <strong>Domino's Pizza Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>)</strong> share price is at $431.24, after a <strong>0.06%</strong> increase. Moreover, over the past month, the stock fell by <strong>9.49%</strong>, but in the past year, increased by <strong>4.55%</strong>. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735222516_0.png" alt="Past Year Chart" /></p>

<h3>Domino's Pizza P/E Compared to Competitors</h3>
<p>The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. </p>
<p>Domino's Pizza has a lower P/E than the aggregate P/E of <strong>81.76</strong> of the Hotels, Restaurants &amp; Leisure industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2024/1735222516_1.png" alt="Guage" /></p>

<p>In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes. </p>


Price Over Earnings Overview: Domino's Pizza

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>There are thousands of U.S.-listed stocks categorized as <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>, or stocks trading for $5 per share or less but only a few can be considered strong buy penny stocks.</p>



<p>&ldquo;Penny stock territory&rdquo; contains a lot of busted growth stories, <a href="https://www.investopedia.com/terms/f/fallenangel.asp">fallen angels</a> and <a href="https://www.investopedia.com/terms/v/valuetrap.asp">value traps</a>, yet dive deep enough into the space, and you&rsquo;ll find plenty of asymmetric opportunities. In other words, stocks where upside potential vastly exceeds downside risk.</p>



<p>There are both growth and value plays within this category. The common denominator is that each of these stocks has one or several potential catalysts that could dramatically increase its respective underlying value.</p>



<p>While not all of them will live up to this potential, and in fact quite a few will miss the mark entirely, in the aggregate owning a basket of such stocks has the potential to produce stunning returns. With this in mind, let&rsquo;s take a look at seven strong buy penny stocks and why risk-hungry investors should consider buying them today.</p>



<h2>Broadwind (BWEN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/06/wind_turbine_1600-300x169.jpg" alt="A wind turbine appears in silhouette against a bright orange and blue sky."><div>Source: Khanthachai C / Shutterstock.com</div></div><p><strong>Broadwind</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/bwen-stock-quote/"><strong>BWEN</strong></a>) is a manufacturer of industrial equipment used in clean energy infrastructure like wind turbines. Outside of the &ldquo;green wave stocks&rdquo; boom of 2021, and the smaller boom in such stocks around the time the Inflation Reduction Act was passed by Congress last year, BWEN has delivered a mixed performance.</p>



<p>However, lately BWEN stock has again been on a tear for reasons more company-specific in nature. That is, investors have jumped back into BWEN due to positive surprises with equipment maker&rsquo;s fiscal performance. Last quarter, the company beat on revenue and <a href="https://seekingalpha.com/news/4105683-broadwind-gaap-eps-of-0_07-beats-0_14-revenue-of-37_62m-beats-2_53m?source=content_type%3Areact%7Csection%3Asummary%7Csection_asset%3Aall_news%7Cfirst_level_url%3Asymbol%7Cbutton%3ATitle%7Clock_status%3ANo%7Cline%3A4">unexpectedly reported positive GAAP earnings</a>. Broadwind also reported a <a href="https://investors.bwen.com/investor-news/investor-news-details/2024/Broadwind-Announces-First-Quarter-2024-Results/default.aspx">43.5%</a> sequential increase in orders.</p>



<p>BWEN bolted from just over $2 per share to nearly $4 per share since this well-received earnings release but the potential for additional upside remains. Forecasts call for Broadwind&rsquo;s earnings to increase sixfold next year, to <a href="https://www.wsj.com/market-data/quotes/BWEN">36 cents per share</a>. Such an improvement may prove sufficient to send the stock to even higher prices.</p>



<h2>Elite Pharmaceuticals (ELTP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/08/pharmaceutical1600-300x169.png" alt="pharmaceutical industry. Production line machine conveyor with glass bottles ampoules at factory"><div>Source: Dmitry Kalinovsky / Shutterstock.com</div></div><p>In the past, I&rsquo;ve named <strong>Elite Pharmaceuticals</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/eltp-stock-quote/"><strong>ELTP</strong></a>) as being one of the strong buy penny stocks. As discussed previously, shares in this over-the-counter (OTC) listed pharma firm delivered <a href="https://investorplace.com/2023/10/q4-stock-predictions-7-penny-stocks-ready-to-roar-into-2024/">an incredible performance during 2023</a>. During that time frame, ELTP went from 3 cents to 14 cents per share.</p>



<p>ELTP stock has continued to gain this year, albeit at a far slower pace compared to the preceding year. However, don&rsquo;t assume that the rate of price appreciation will continue to slow down to a trickle. Why? The company justed received Food and Drug Administration (FDA) <a href="https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=134477&amp;BzID=2258&amp;g=939&amp;Nav=0&amp;LangID=1&amp;s=0">approval for a generic methotrexate drug product</a>. Methotrexate is an anti-rheumatic drug with a total annual addressable market estimated at $64.3 million.</p>



<p>That may sound like chump change for big pharma, yet for micro-cap ELTP it could really be a game-changer in terms of its operating performance in the years ahead. Last year, Elite&rsquo;s revenue totaled just $47.3 million. The stock currently trades at an inexpensive 10.8 times trailing 12 month (TTM) earnings. Alongside the prospect of rising in line with increased earnings, there may be potential for shares to be re-rated to a higher valuation.</p>



<h2>E2 Open Parent Holdings (ETWO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/06/supply-chain-forklift-workers-1600-300x169.jpg" alt="silhouettes of a forklift and driver as well as two workers by a semi truck backdropped by a sunset sky. represents the supply chain"><div>Source: shutterstock.com/By yuttana Contributor Studio</div></div><p><strong>E2 Open Parent Holdings</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/etwo-stock-quote/"><strong>ETWO</strong></a>) has more than doubled since October, but the incredible run in this supply chain management software purveyor may not be over. <a href="https://www.bloomberg.com/news/articles/2023-10-16/elliott-said-to-mull-buyout-of-supply-chain-software-firm-e2open">Shareholder activism and buyout rumors</a> have been a major factor behind ETWO&rsquo;s strong performance during this time frame.</p>



<p>In March the company announced it was beginning a <a href="https://seekingalpha.com/news/4077204-e2open-soars-after-announcing-start-of-strategic-review?source=content_type%3Areact%7Csection%3Asummary%7Csection_asset%3Aall_news%7Cfirst_level_url%3Asymbol%7Cbutton%3ATitle%7Clock_status%3ANo%7Cline%3A5">&ldquo;strategic review,&rdquo;</a> which may include a sale of the company. ETWO stock has traded sideways since, but any news regarding a buyout could lead to another rally. That&rsquo;s not all. Even if takeover rumors ultimately fall apart, further improvement in E2 Open&rsquo;s operating performance may do the trick.</p>



<p>As <em>InvestorPlace Earnings</em> reported on Apr. 29, E2 Open <a href="https://investorplace.com/earning-results/2024/04/etwo-stock-earnings-e2open-parent-holdings-for-q4-of-2024/">beat on revenue and earnings</a> during the company&rsquo;s fiscal fourth quarter ending Feb. 29. Given that this $4.50 per share penny stock previously traded in the low-teens, even a partial recovery would represent big upside.</p>



<h2>Lesaka Technologies (LSAK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/smartphone-mobile-financial-fintech-1600-300x169.jpg" alt="Illustration of phone with dollar sign and other graphics symbolizing fintech displayed on and around it, with a blue background. Fintech Stock Bargains. fintech stocks to buy"><div>Source: shutterstock.com/ZinetroN</div></div><p>I&rsquo;ve writen multiple times <strong>Lesaka Technologies</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/lsak-stock-quote/"><strong>LSAK</strong></a>) is a <a href="https://investorplace.com/2024/05/7-fintech-stocks-to-buy-now-may-2024/">one of the best fintech stocks</a>. It is also <a href="https://investorplace.com/2024/05/investing-in-the-future-3-promising-penny-stocks-to-watch/">one of the strong buy penny stocks</a>. This South Africa-based fintech firm provides payment technology services in its home market and adjacent markets in Southern Africa. So far this year, the announcement of strategic acquisitions has bolstered confidence in the company&rsquo;s turnaround.</p>



<p>By acquiring competitors, Lesaka is positioning itself as the leading fintech services provider for South Africa&rsquo;s informal economy. The mergers will also likely produce significant cost savings, enabling the company to reach consistent profitability. While not certain, South Africa&rsquo;s recent general election may explain why LSAK stock has lost momentum after surging from $3.50 to nearly $5 per share.</p>



<p>Uncertainty exists over the African National Congress (ANC) needing to form a coalition government. It failed to win a majority and it was unknown whether the ANC would  form one with centrist, pro-business parties or with parties less favorable to business and foreign investment. However, the latest developments suggest the planned Government of National Unity will <a href="https://www.reuters.com/world/africa/south-africa-is-forming-unity-government-what-happens-next-2024-06-12/">consist of the former</a> rather than the latter.</p>



<h2>Moberg Pharma (MBGPF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/syringe-needle-biopharma-1600-1-300x169.jpg" alt="A syringe with a safety cap and a surgical mask laid out on a blank background"><div>Source: shutterstock.com/Michele Ursi</div></div><p><strong>Moberg Pharma</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/mbgpf-stock-quote/"><strong>MBGPF</strong></a>) is a Sweden-based pharmaceutical company focused primarily on the development of a nail fungus treatment. Since publication of a <a href="https://leftfieldinvesting.substack.com/p/moberg-pharma">bullish write-up</a> by <em>Left Field Investing</em> last November, this obscure company in a decidedly unglamorous business has <a href="https://twitter.com/search?q=Moberg%20Pharma&amp;src=typed_query&amp;f=live">garnered increased attention</a> among members of <strong>X&rsquo;s</strong> (formerly Twitter) &ldquo;Fintwit&rdquo; community.</p>



<p>Here&rsquo;s the bull case in a nutshell for Moberg. After <a href="https://www.mobergpharma.com/node/3560">success</a><span><a href="https://investorplace.com/stock-quotes/-stock-quote/"></a></span><a href="https://www.mobergpharma.com/node/3560">fully launching its treatment</a> Terclara in its home market, Moberg is now focused on commercializing it globally. The company thus far has inked commercial partnerships in five jurisdictions, including the European Union and Canada. Given the size of the total addressable market for this treatment and its Swedish market share, Moberg&rsquo;s target of up to <a href="https://www.mobergpharma.com/sites/default/files/moberg_pharma_q1_2024_240507_0.pdf">$500 million</a> in global product sales may be more than reasonable.</p>



<p>Not bad for a company with a market cap of just under $75 million. You can buy Moberg stateside in the OTC market where it trades as MBGPF stock. However, if you have access, a more liquid option may be to buy it via Moberg&rsquo;s main stock market listing, on the <strong>NASDAQ OMX Stockholm Nordic Exchange</strong>.</p>



<h2>New Gold (NGD)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/12/gold-300x169.jpg" alt="A pile of shining gold bars. Gold stocks"><div>Source: Shutterstock</div></div><p><strong>New Gold</strong> (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ngd-stock-quote/"><strong>NGD</strong></a>) is a Canada-based gold mining company. The company&rsquo;s main asset is its interest in the Rainy River mine, located in Northwestern Ontario. As you likely know, gold prices, while pulling back lately, have been rising in recent months.</p>



<p>NGD stock has spiked in price alongside this surge. Trading for just over $1 per share in February, New Gold is now at prices nearing $2 per share. Even if it seems that the gold rally is losing momentum, that may not necessarily be the case for NGD. At least, that&rsquo;s the takeaway from <a href="https://seekingalpha.com/news/4112012-new-gold-resumed-at-outperform-at-bmo-after-increasing-new-afton-stake?source=content_type%3Areact%7Csection%3Asummary%7Csection_asset%3Aall_news%7Cfirst_level_url%3Asymbol%7Cbutton%3ATitle%7Clock_status%3ANo%7Cline%3A1">the recent reiteration of an &ldquo;Outperform&rdquo; rating</a> on the stock by BMO&rsquo;s Brian Quast.</p>



<p>On May 31, the sell-sider published a bullish research note on NGD. He cited significant increases in free cash flow ahead primarily due to New Gold increasing its interest in its New Afton copper and gold mine located in British Columbia. Trading for a reasonable 13.2 times forward earnings, the opportunity for increased cash flow could lead to further price appreciation for shares. In the event gold prices keep rising, this could be icing on the cake in terms of upside potential.</p>



<h2>Pitney Bowes (PBI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/08/pbi-stock-1-300x169.jpg" alt="The office logo for Pitney Bowes on a glass building."><div>Source: JHVEPhoto / Shutterstock.com</div></div><p>Admittedly, <strong>Pitney Bowes</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/pbi-stock-quote/"><strong>PBI</strong></a>) is technically a penny stock right now. With a share price of $5.13 per share, PBI is just above what I like to call the &ldquo;penny stock ceiling.&rdquo; Even so, buying in now could still result in the sort of significant upside investors seek when investing in low-priced penny stocks.</p>



<p>As I&rsquo;ve discussed numerous times in coverage of PBI stock, an activist-led turnaround could result in <a href="https://investorplace.com/2024/04/dividend-diamonds-in-the-rough-7-undervalued-income-stocks/">the significant unlocking of shareholder value</a>. Obviously, with the stock up by 42.1% over the past year, this has already started to happen. Still, far greater upside may lie ahead. From the start activist investor Hestia Capital has estimated Pitney Bowes could eventually be worth between $11.34 and $16.33 per share.</p>



<p>Although Hestia and PBI still have plenty of work to do, recent developments signal they remain on track. As noted in a press release issued last month, PBI appointed a new interim CEO and announced plans to reduce annual operating expenses by as much as <a href="https://www.investorrelations.pitneybowes.com/news-releases/news-release-details/pitney-bowes-announces-leadership-transition-and-new-initiatives">$100 million</a>. It is also finalizing a strategic review that may result in a sale of one of Pitney Bowes&rsquo; subsidiaries.</p>



<p><em><strong>On Penny Stocks and Low-Volume Stocks:</strong>&nbsp;With only the rarest exceptions,&nbsp;InvestorPlace does not publish commentary about companies that have a market cap of&nbsp;less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because&nbsp;these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market&nbsp;manipulators. If we ever do publish commentary on a low-volume stock that may be&nbsp;affected by our commentary, we demand that InvestorPlace.com&rsquo;s writers disclose this&nbsp;fact and warn readers of the risks.</em></p>



<p><strong><em>Read More:&nbsp;</em></strong><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/"><em>Penny Stocks &mdash; How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, Thomas Niel held LSAK. He did not hold (either directly or indirectly) any positions in the other securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com </em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em>Publishing Guidelines</em></a><em>.</em></p>
<div><p>Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/06/7-strong-buy-penny-stocks-to-buy-now-june-2024/">7 Strong Buy Penny Stocks to Buy Now: June 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Comments

Moberg Pharma

Moberg Pharma (MBGPF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga